Literature DB >> 26160020

Antimitotic and antivascular activity of heteroaroyl-2-hydroxy-3,4,5-trimethoxybenzenes.

Hsueh-Yun Lee1, Chih-Yi Chang1, Mei-Jung Lai2, Hsun-Yueh Chuang1, Ching-Chuan Kuo3, Chi-Yen Chang4, Jang-Yang Chang5, Jing-Ping Liou6.   

Abstract

This study reports the synthesis of a series of heteroaroyl-2-hydroxy-3,4,5-trimethoxybenzenes, which are potent antitubulin agents. Compound 13, (2-hydroxy-3,4,5-trimethoxyphenyl)-(6-methoxy-1H-indol-3-yl)-methanone exhibits marked antiproliferative activity against KB and MKN45 cells with IC50 values of 8.8 and 10.5 nM, respectively, binds strongly to the colchicine binding site and leads to inhibition of tubulin polymerization. It also behaves as a vascular disrupting agent which suppresses the formation of capillaries. The C2-OH group in the A-ring of this compound not only retains the biological activity but has valuable physicochemical properties.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Antiproliferative; CA-4; Vascular-disrupting agents

Mesh:

Substances:

Year:  2015        PMID: 26160020     DOI: 10.1016/j.bmc.2015.06.043

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  3 in total

1.  A simple and convenient synthesis of 3-salicyloylquinoline-4-carboxylic esters from chromone and isatin.

Authors:  Xuequan Wang; Zhixin Yang; Weihang Miu; Pingting Ye; Mengjiao Bai; Suyue Duan; Xianfu Shen
Journal:  RSC Adv       Date:  2019-11-12       Impact factor: 4.036

2.  Synthesis and biological evaluation of isomeric methoxy substitutions on anti-cancer indolyl-pyridinyl-propenones: Effects on potency and mode of activity.

Authors:  Christopher J Trabbic; Sage M George; Evan M Alexander; Shengnan Du; Jennifer M Offenbacher; Emily J Crissman; Jean H Overmeyer; William A Maltese; Paul W Erhardt
Journal:  Eur J Med Chem       Date:  2016-06-13       Impact factor: 6.514

3.  Design, synthesis and structure-activity relationship of 3,6-diaryl-7H-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazines as novel tubulin inhibitors.

Authors:  Qile Xu; Kai Bao; Maolin Sun; Jingwen Xu; Yueting Wang; Haiqiu Tian; Daiying Zuo; Qi Guan; Yingliang Wu; Weige Zhang
Journal:  Sci Rep       Date:  2017-09-20       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.